adplus-dvertising
Connect with us

Health

Cancer survivors face dilemma over banned breast implants linked to rare lymphoma – CBC.ca

Published

 on


Dona Murphy was finally feeling relieved. Eight years after being diagnosed with breast cancer and having a mastectomy, her oncologist declared her cancer-free.

Then in November, she received a couriered letter from the hospital where she had her surgery, delivering some shocking news: The breast implant used during her reconstruction was now banned by Health Canada.

Last May, Health Canada pulled a type of textured breast implant off the market, following a joint investigation by CBC News, Radio-Canada, the Toronto Star and the Washington-based International Consortium of Investigative Journalists.

The product — specifically macro-textured Biocell implants, made by Allergan — has been linked to a rare form of lymphoma known as breast-implant-associated anaplastic large cell lymphoma, or BIA-ALCL.

Health Canada says it’s a “serious but rare type of lymphoma,” with the agency pegging the risk of BIA-ALCL at one in 3,565 (0.03%) for the Biocell implants. In Canada, more than 30 women have been diagnosed with BIA-ALCL.

Dona Murphy reads a letter from the hospital where she underwent a mastectomy after being diagnosed with breast cancer; it informed her that the implant used in the surgery has since been banned by Health Canada. (CBC)

Regulators in both Canada and the U.S. don’t recommend that women with the implants have them removed because the cancer is so rare. But they say women should check with their doctor if they have any symptoms, which include pain and swelling.

Paying for peace of mind?

While Murphy has no symptoms from her textured implant, she wants the device removed from her body. But the Ontario government has said that if the implant doesn’t affect her health, it’s up to her to pay to have it taken out.

“I can’t imagine why any woman would want to have it in them if there’s a potential — no matter how small — of causing cancer,” she said.

Patricia Mailman has two textured implants, put in after undergoing a double mastectomy in Halifax as part of her cancer treatment. When she found out about the ban, she too immediately wanted her implants replaced with non-textured ones.

She doesn’t have $10,000 needed to pay a plastic surgeon to have the explant done, she said, so she’s on a waiting list to have the Nova Scotia government pay, because the implants are causing her pain.

“We didn’t ask for the cancer in the first place, so we didn’t really ask for this either,” Mailman said.

Patricia Mailman had textured implants put in years ago after a double mastectomy. (CBC)

Textured breast implants were used in thousands of procedures in Canada beginning in 2006, with the pebble-like surface intended to act as a kind of Velcro, preventing the implant from sliding on the chest well.

The medical community started linking some breast implants to cancer in 2011.

BIA-ALCL is not breast cancer, but rather lymphoma that grows in the scar tissue surrounding the breast. It grows slowly and can usually be successfully treated by surgically removing the implants.

Risks involved with removal

Dr. Michael Weinberg, a plastic surgeon in Toronto, estimates he’s implanted about 100 pairs of textured implants. Now because of the ban, he says some of his former patients are scared, worried and asking for his advice.

“They are very emotional and I completely understand how they feel really badly,” he said.

Weinberg cautions that removing implants is a significant operation, both in terms of medical risks, as well as cosmetically.

The risks of implant removal include:

  • Infection.
  • Bleeding.
  • Scarring.

“You can’t guarantee when the implant is under the muscle that you’ll be able to take the whole capsule out,” said Weinberg, or the surrounding scar tissue that can stick to the ribs.

Still, for some women, the thought of possibly developing cancer is a worse risk.

Murphy is scheduled to have her implant removed in March, paying for it out of her own pocket. But, she points out, that’s something a lot of women can’t afford to do.

Cancer survivors are faced with difficult decisions months after textured implants were banned because of a rare cancer risk. The women must decide if the risks and costs of having implants removed outweigh the risk of leaving them in. 2:19

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending